bioRxiv ScienceSearch

bioRxiv · 10.1101/529982

Oscillations, criticality and responsiveness in complex brain networks

Abstract

Brain networks during unconscious states resulting from sleep, anesthesia, or traumatic injuries are associated with a limited capacity for complex responses to stimulation. Even during the conscious resting state, responsiveness to stimulus is highly dependent on spontaneous brain activities. Many empirical findings have been suggested that the brain responsiveness is determined mainly by the ongoing brain activity when a stimulus is given. However, there has been no systematic study exploring how such various brain activities with high or low synchronization, amplitude, and phase response to stimuli. In this model study, we simulated large-scale brain network dynamics in three brain states (below, near, and above the critical state) and investigated a relationship between ongoing oscillation properties and a stimulus decomposing the brain activity into fundamental oscillation properties (instantaneous global synchronization, amplitude, and phase). We identified specific stimulation conditions that produce varying levels of brain responsiveness. When a single pulsatile stimulus was applied to globally desynchronized low amplitude of oscillation, the network generated a large response. By contrast, when a stimulus was applied to specific phases of oscillation that were globally synchronized with high amplitude activity, the response was inhibited. This study proposes the oscillatory conditions to induce specific stimulation outcomes in the brain that can be systematically derived from networked oscillator properties, and reveals the presence of state-dependent temporal windows for optimal brain stimulation. The identified relationship will help advance understanding of the small/large responsiveness of the brain in different states of consciousness and suggest state-dependent methods to modulate responsiveness. Author SummaryA responsiveness of the brain network to external stimulus is different across brain states such as wakefulness, sleep, anesthesia, and traumatic injuries. It has been shown that responsiveness of the brain during conscious state also varies due to the diverse transient states of the brain characterized by different global and local oscillation properties. In this computational model study using large-scale brain network, we hypothesized that the brain responsiveness is determined by the interactions of networked oscillators when a stimulus is applied to the brain. We examined relationships between responsiveness of the brain network, global synchronization levels, and instantaneous oscillation properties such as amplitude and phase in different brain states. We found specific stimulation conditions of the brain that produce large or small levels of responsiveness. The identified relationship suggests the existence of temporal windows that periodically inhibit sensory information processing during conscious state and develops state-dependent methods to modulate brain responsiveness considering dynamically changed functional brain network.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Kim, M., Lee, U.. 2019-01-24. Oscillations, criticality and responsiveness in complex brain networks. https://doi.org/10.1101/529982

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience